Treatment for Epilepsy

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stanford University School of Medicine, Palo Alto, CAEpilepsy
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will investigate how ketamine causes dissociative symptoms by looking at how it affects the brain.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
T-allo10 cells addback
1
Gamma Delta T-Cell Infusion
1
EAGD T-cell infusion (Expansion)

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: up to 1 week

up to 1 week
Number of participants with dissociative events during ketamine infusion as assessed by CADSS (Clinician-Administered Dissociative State Scale)

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
T-allo10 cells addback
1
Gamma Delta T-Cell Infusion
1
EAGD T-cell infusion (Expansion)

Trial Design

0 Treatment Group

20 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 1

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 week

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,186 Previous Clinical Trials
35,092,530 Total Patients Enrolled
13 Trials studying Epilepsy
1,162 Patients Enrolled for Epilepsy
Karl Deisseroth, MD, PhD1.01 ReviewsPrincipal Investigator - Stanford University
Stanford University
1Patient Review
I was very uncomfortable around him. He was dismissive of my concerns about side effects and just increased the dosage. He spoke to me in a condescending way and made personal and sexual accusations. I would not recommend him to anyone.

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What potential hazards does this treatment pose to individuals?

"Our team at Power ranks the safety of this medical intervention as a 1, considering it is only in Phase 1. This indicates that there are limited studies to back its efficacy and safety." - Anonymous Online Contributor

Unverified Answer

How many participants are engaged in this experiment?

"Indeed, the information available on clinicaltrials.gov affirms that enrollment is ongoing for this medical research project. The initial posting was made on July 26th 2021 and the details were most recently updated on October 25th 2022. A total of 20 participants are required to be recruited from one site only." - Anonymous Online Contributor

Unverified Answer

Can individuals still join this experiment?

"Correct. According to clinicaltrials.gov, this medical investigation is currently open for participants; the initial posting date was July 26th 2021 and it underwent a recent modification on October 25th 2022. Currently, 1 site requires 20 individuals in order to start the study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top